“We are excited to welcome Briggs to our Board of Directors,” said Samarth Kulkarni, Ph.D., Chief Executive Officer and Chairman of the Board of CRISPR Therapeutics. “His extensive ...
a strong balance sheet and an organizational foundation to drive our pipeline forward,” said Samarth Kulkarni, Ph.D., Chairman and Chief Executive Officer of CRISPR Therapeutics. “Building on ...
In other news, CEO Samarth Kulkarni sold 30,000 shares of CRISPR Therapeutics stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $55.62 ...
“We are excited to welcome Briggs to our Board of Directors,” said Samarth Kulkarni, Ph.D., Chief Executive Officer and Chairman of the Board of CRISPR Therapeutics. “His extensive experience in the ...
a strong balance sheet and an organizational foundation to drive our pipeline forward,” said Samarth Kulkarni, Ph.D., Chairman and Chief Executive Officer of CRISPR Therapeutics. “Building on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback